| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Reduced lung-cancer mortality with low-dose computed tomographic screening.
|
N Engl J Med
|
2011
|
38.61
|
|
2
|
Mortality results from a randomized prostate-cancer screening trial.
|
N Engl J Med
|
2009
|
30.05
|
|
3
|
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
|
J Natl Cancer Inst
|
2012
|
11.91
|
|
4
|
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.
|
N Engl J Med
|
2012
|
11.48
|
|
5
|
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
|
JAMA
|
2011
|
9.13
|
|
6
|
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.
|
JAMA
|
2011
|
6.45
|
|
7
|
Performance of common genetic variants in breast-cancer risk models.
|
N Engl J Med
|
2010
|
5.79
|
|
8
|
Comorbidity and mortality results from a randomized prostate cancer screening trial.
|
J Clin Oncol
|
2010
|
4.84
|
|
9
|
Results from four rounds of ovarian cancer screening in a randomized trial.
|
Obstet Gynecol
|
2009
|
3.59
|
|
10
|
Utilization of surveillance colonoscopy in community practice.
|
Gastroenterology
|
2009
|
3.33
|
|
11
|
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
|
Clin Trials
|
2010
|
2.38
|
|
12
|
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
|
J Natl Cancer Inst
|
2011
|
2.31
|
|
13
|
Cumulative incidence of false-positive results in repeated, multimodal cancer screening.
|
Ann Fam Med
|
2009
|
1.94
|
|
14
|
Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer.
|
Clin Gastroenterol Hepatol
|
2012
|
1.44
|
|
15
|
Incidence and Mortality of Colorectal Cancer in Individuals With a Family History of Colorectal Cancer.
|
Gastroenterology
|
2015
|
1.40
|
|
16
|
Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence.
|
JAMA
|
2018
|
1.38
|
|
17
|
Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations.
|
Am J Clin Nutr
|
2014
|
1.35
|
|
18
|
Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
|
J Natl Cancer Inst
|
2010
|
1.29
|
|
19
|
Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.
|
J Natl Cancer Inst
|
2012
|
1.27
|
|
20
|
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
|
BMC Cancer
|
2009
|
1.22
|
|
21
|
Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
|
Am J Epidemiol
|
2010
|
1.21
|
|
22
|
Prediction of true positive lung cancers in individuals with abnormal suspicious chest radiographs: a prostate, lung, colorectal, and ovarian cancer screening trial study.
|
J Thorac Oncol
|
2009
|
1.03
|
|
23
|
Ovarian cancer screening in women with a family history of breast or ovarian cancer.
|
Obstet Gynecol
|
2006
|
0.99
|
|
24
|
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context.
|
Acta Oncol
|
2011
|
0.92
|
|
25
|
Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer.
|
Am J Clin Nutr
|
2015
|
0.88
|
|
26
|
Factors associated with human small aggressive non small cell lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.87
|
|
27
|
Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer.
|
J Nutr
|
2014
|
0.83
|
|
28
|
Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
|
Cancer Epidemiol
|
2012
|
0.81
|
|
29
|
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
|
Gynecol Oncol
|
2016
|
0.79
|
|
30
|
Diagnostic evaluation following a positive lung screening chest radiograph in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial.
|
Lung Cancer
|
2013
|
0.75
|
|
31
|
Interval lung cancers not detected on screening chest X-rays: How are they different?
|
Lung Cancer
|
2014
|
0.75
|